Trials / Completed
CompletedNCT00355446
Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
Bioavailabilty of Bimatoprost Ophthalmic Solution in Human Aqueous.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (planned)
- Sponsor
- Indiana University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assay human aqueous for bimatoprost and the presence of any metabolites, especially prostaglandin analogs. Hypothesis:Bimatoprost is not metabolized to a prostaglandin F-2-alpha analog in human eyes * Bimatoprost levels in human aqueous peak approximately three hours post dosing
Detailed description
The purpose of this study is to assay human aqueous for bimatoprost and the presence of any metabolites, especially prostaglandin analogs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bimatoprost 0.03% |
Timeline
- Start date
- 2001-07-01
- Completion
- 2004-10-01
- First posted
- 2006-07-24
- Last updated
- 2007-10-17
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00355446. Inclusion in this directory is not an endorsement.